http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23502841

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
issn 1748-717X
issueIdentifier 1
pageRange 114-
publicationName Radiation oncology (London, England)
startingPage 114
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_23054fa54c8bc0997cff204bca4385da
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_de2e5fe8163f1525dc1533dc7c355fe5
bibliographicCitation Davies JM, Trembath D, Deal AM, Funkhouser WK, Calvo BF, Finnegan T, Weck KE, Tepper JE, O'Neil BH. Phospho-ERK and AKT status, but not KRAS mutation status, are associated with outcomes in rectal cancer treated with chemoradiotherapy. Radiation Oncology. 2011 Sep 12;6(1):114. doi: 10.1186/1748-717x-6-114.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_03d8e39e4ac6fa0a928d0c2a37b49a3c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a18d515bdb7535fcdde65fc528302cb8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c957ea967d3e9193a55d3494394f872d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a21fefd560f27a201b5dbc1cba09fdd4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0ec52c4da677da6fd1d0e8c8b5a4329
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4070b86972e1bc2e975e09d12d323245
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_056916456545609355b8bbb45543b538
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc99583aff88c5abf403ada0933bd3f0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25fdf4c97da64740875e1acc72f611de
date 2011-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1186/1748-717x-6-114
https://pubmed.ncbi.nlm.nih.gov/21910869
https://pubmed.ncbi.nlm.nih.gov/PMC3180690
isPartOf https://portal.issn.org/resource/ISSN/1748-717X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32756
language English
source https://scigraph.springernature.com/
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Phospho-ERK and AKT status, but not KRAS mutation status, are associated with outcomes in rectal cancer treated with chemoradiotherapy
discusses http://id.nlm.nih.gov/mesh/M0027004
http://id.nlm.nih.gov/mesh/M0027924
http://id.nlm.nih.gov/mesh/M0150739
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9060
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1c50845b337a3c11fa194521642a3ec8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127676247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128611606
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128482492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129430288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129771248
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID207

Total number of triples: 46.